Trials / Completed
CompletedNCT03220308
Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting
Mindfulness Training for Children With ADHD and Mindful Parenting
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Karakter Kinder- en Jeugdpsychiatrie · Academic / Other
- Sex
- All
- Age
- 8 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effectiveness of an 8-week mindfulness group training for children (8-16 years old) with ADHD in combination with a parallel mindful parenting training for their parents. Half of the participants will be randomly assigned to the mindfulness training in addition to care-as-usual (CAU); the other half to CAU-only. The hypothesis is that compared to care-as-usual only, the addition of the mindfulness training will improve self-control of youth with ADHD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MYmind mindfulness training | The MYmind mindfulness training uses a standardised protocol based on mindfulness-based cognitive therapy. It consists of 8 weekly group sessions of 90 minutes for youth with ADHD, and parallel mindful parenting training for the parents. Eight weeks after the last session there is a single 90 minutes booster session. |
| OTHER | Care-as-usual for children (8-16 years old) with ADHD | According to the Dutch Multidisciplinary guidelines for the diagnosis and treatment of ADHD, care-as-usual for children aged 8-16 years with ADHD consists of psycho-education and the prescription of medication approved for ADHD and/or evidence-based parent and/or teacher-administered behaviour therapy, preferably both medication and behaviour therapy. First-line option for medication is a psychostimulant, second-line option is atomoxetine, and third-line options are alpha-2 presynaptic agonists or tricyclic antidepressants (imipramine). |
Timeline
- Start date
- 2016-02-18
- Primary completion
- 2018-07-26
- Completion
- 2019-02-22
- First posted
- 2017-07-18
- Last updated
- 2019-03-07
Locations
3 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03220308. Inclusion in this directory is not an endorsement.